Jpmorgan Chase & CO Pro Mis Neurosciences Inc. Transaction History
Jpmorgan Chase & CO
- $1.14 Trillion
- Q2 2024
A detailed history of Jpmorgan Chase & CO transactions in Pro Mis Neurosciences Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 3 shares of PMN stock, worth $3. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3
Previous 253
98.81%
Holding current value
$3
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding PMN
# of Institutions
17Shares Held
3.26MCall Options Held
0Put Options Held
0-
Sphera Funds Management Ltd. Tel Aviv, L31.81MShares$2.09 Million0.4% of portfolio
-
Ally Bridge Group (Ny) LLC New York, NY1.06MShares$1.22 Million1.49% of portfolio
-
Affinity Asset Advisors, LLC New York, NY266KShares$305,8510.05% of portfolio
-
Bank Of Montreal Toronto, A630.4KShares$34,9200.0% of portfolio
-
Hara Capital LLC Bellevue, WA29.4KShares$33,8280.02% of portfolio
About ProMIS Neurosciences Inc.
- Ticker PMN
- Exchange OTC
- Description
- ProMIS Neurosciences, Inc. discovers and develops precision medicine solutions for the treatment of neurodegenerative diseases, primarily Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA) in Canada. The company's proprietary discovery platform comprises ProMIS and Collective Coordinates algorithms t...